Spanish (IBEX) Biotech Industry Analysis
UpdatedJan 27, 2023
DataAggregated Company Financials
Companies5
- 7D3.2%
- 3M41.0%
- 1Y-17.3%
- YTD8.6%
In the last week, Biotech has been flat. Unfortunately though, the industry is down 19% over the past 12 months. Looking forward, earnings are forecast to grow by 27% annually.
Industry Valuation and Performance
Has the Spanish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 27 Jan 2023 | €8.7b | €5.5b | €137.1m | 78x | 63.6x | 1.6x |
| Sun, 25 Dec 2022 | €7.9b | €5.5b | €137.0m | 69.3x | 58x | 1.5x |
| Tue, 22 Nov 2022 | €7.5b | €5.5b | €136.9m | 63.9x | 54.4x | 1.4x |
| Thu, 20 Oct 2022 | €6.2b | €5.5b | €136.8m | 53.5x | 45.4x | 1.1x |
| Sat, 17 Sep 2022 | €8.3b | €5.5b | €136.8m | 73.2x | 60.6x | 1.5x |
| Mon, 15 Aug 2022 | €9.3b | €5.5b | €136.8m | 84.9x | 68.1x | 1.7x |
| Wed, 13 Jul 2022 | €11.1b | €5.2b | €266.2m | 37.9x | 41.9x | 2.2x |
| Fri, 10 Jun 2022 | €12.4b | €5.2b | €266.4m | 41.8x | 46.6x | 2.4x |
| Sun, 08 May 2022 | €12.3b | €5.2b | €266.3m | 41.7x | 46.2x | 2.4x |
| Tue, 05 Apr 2022 | €11.7b | €5.2b | €268.5m | 39.4x | 43.6x | 2.3x |
| Thu, 03 Mar 2022 | €11.5b | €5.1b | €236.6m | 41.1x | 48.6x | 2.2x |
| Sat, 29 Jan 2022 | €10.4b | €5.4b | €721.7m | 16x | 14.4x | 1.9x |
| Mon, 27 Dec 2021 | €10.5b | €5.4b | €721.8m | 16.5x | 14.6x | 2x |
| Wed, 24 Nov 2021 | €11.4b | €5.4b | €721.7m | 17.4x | 15.8x | 2.1x |
| Fri, 22 Oct 2021 | €13.3b | €5.4b | €729.0m | 20.2x | 18.2x | 2.4x |
| Sun, 19 Sep 2021 | €14.2b | €5.4b | €729.0m | 21.8x | 19.5x | 2.6x |
| Tue, 17 Aug 2021 | €13.3b | €5.4b | €729.0m | 18.6x | 18.3x | 2.5x |
| Tue, 01 Jun 2021 | €15.1b | €5.5b | €648.5m | 19.7x | 23.3x | 2.8x |
| Fri, 05 Mar 2021 | €14.5b | €5.6b | €750.7m | 17.3x | 19.3x | 2.6x |
| Mon, 07 Dec 2020 | €16.1b | €5.6b | €830.9m | 16.4x | 19.4x | 2.9x |
| Thu, 10 Sep 2020 | €14.9b | €5.6b | €677.0m | 18.2x | 22x | 2.7x |
| Wed, 03 Jun 2020 | €17.9b | €5.4b | €765.4m | 21.3x | 23.5x | 3.3x |
| Sat, 07 Mar 2020 | €17.7b | €5.1b | €618.5m | 28x | 28.6x | 3.5x |
Price to Earnings Ratio
29.8x
Current Industry PE
- Investors are optimistic on the Spanish Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 62.3x which is higher than its 3-year average PE of 30.1x.
- The 3-year average PS ratio of 2.5x is higher than the industry's current PS ratio of 1.6x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have declined 39% per year over the last three years.
- Meanwhile revenues for these companies have grown 2.2% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Spanish Healthcare industry?
| ES Market | 2.49% | |
| Healthcare | 2.57% | |
| Biotech | 3.18% | |
| Biotech | 3.18% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GRF Grifols | €12.56 | 4.1% +€339.5m | -20.1% | PE143x | |
| ORY Oryzon Genomics | €2.61 | 1.0% +€1.3m | -14.3% | PS14.6x |